Treatment method with SR18662 considerably lessens growth and proliferation of CRC cells. SR18662 reveals improved efficacy in minimizing viability of numerous CRC cell strains. Movement cytometry Examination pursuing SR18662 remedy exhibits an increase in cells captured in both S or G2/M phases with the mobile cycle and a substantial increase https://antoniov752lqv5.wikicorrespondence.com/user